The importance of differentiating behavioural and psychological treatment effects from placebo in respiratory interventions
- PMID: 31023864
- DOI: 10.1183/13993003.00156-2019
The importance of differentiating behavioural and psychological treatment effects from placebo in respiratory interventions
Conflict of interest statement
Conflict of interest: B Ainsworth has nothing to disclose. Conflict of interest: D. Hardman has nothing to disclose. Conflict of interest: M. Thomas has received speaker's honoraria for speaking at sponsored meetings or satellite symposia at conferences from the following companies marketing respiratory and allergy products: GSK and Novartis; has received honoraria for attending advisory panels with: Boehringer Ingelhiem, GSK and Novartis; is a recent a member of the BTS SIGN asthma guideline steering group and the NICE asthma diagnosis and monitoring guideline development group.
Comment on
-
Sertraline or placebo in chronic breathlessness? Lessons from placebo research.Eur Respir J. 2019 Jan 17;53(1):1802225. doi: 10.1183/13993003.02225-2018. Print 2019 Jan. Eur Respir J. 2019. PMID: 30655451 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources